LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 54 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $82,032 | -53.2% | 8,699 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $175,111 | -99.9% | 8,699 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $253,749,000 | +39.6% | 8,699 | +42.5% | 0.00% | +33.3% |
| Q1 2018 | $181,807,000 | +92658.7% | 6,105 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $196,000 | -54.7% | 6,105 | -50.9% | 0.00% | 0.0% |
| Q3 2017 | $433,000 | +17.0% | 12,444 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $370,000 | +30.3% | 12,444 | +30.8% | 0.00% | +50.0% |
| Q1 2017 | $284,000 | +70.1% | 9,512 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $167,000 | -47.3% | 9,512 | -28.7% | 0.00% | -50.0% |
| Q3 2016 | $317,000 | +48.8% | 13,341 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $213,000 | -23.7% | 13,341 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $279,000 | +17.2% | 13,341 | +51.3% | 0.00% | 0.0% |
| Q4 2015 | $238,000 | -2.9% | 8,820 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $245,000 | +13.4% | 8,820 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $216,000 | – | 8,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 4,138,893 | $123,256,000 | 18.11% |
| Broadfin Capital, LLC | 1,656,720 | $49,337,000 | 7.69% |
| SECTORAL ASSET MANAGEMENT INC | 1,128,219 | $33,598,000 | 3.68% |
| Perceptive Advisors | 4,313,611 | $128,459,000 | 3.60% |
| RTW INVESTMENTS, LP | 1,122,540 | $33,429,000 | 3.18% |
| Asymmetry Capital Management, L.P. | 55,864 | $1,664,000 | 2.08% |
| EMORY UNIVERSITY | 77,335 | $2,303,000 | 1.64% |
| Monashee Investment Management LLC | 185,000 | $5,509,000 | 1.52% |
| SPHERA FUNDS MANAGEMENT LTD. | 260,000 | $7,743,000 | 1.18% |
| Stanley-Laman Group, Ltd. | 167,825 | $4,998,000 | 1.14% |